Characterization and clinical course of hepatobiliary carcinoma in patients with primary sclerosing cholangitis

References

• Chapman RWG, Marborgh BA, Rhodes JM, Summerfield JA, Dick R, Scheuer PJ. Primary sclerosing cholangitis: a review of clinical features, cholangiography and hepatic histology. Gut 1980; 21: 870–7
   PubMed Web of Science ®Google Scholar
• LaRusso NF, Wiesner RH, Ludwig J, McCarthy RL. Primary sclerosing cholangitis. N Engl J Med 1984; 310: 899–903
   PubMed Web of Science ®Google Scholar
• Wiesner RH, Grambsch PB, Dickson ER, Ludwig J, MacCarty RL, Hunter EB, et al. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 1989; 10: 430–6
   PubMed Web of Science ®Google Scholar
• Schrumpf E, Abdelnoor M, Fausa O, Elgjo K, Jenssen E, Kolmannskog F. Risk factors in primary sclerosing cholangitis. J Hepatol 1994; 21: 1061–6
   PubMed Web of Science ®Google Scholar
• Broomé U, Olsson R, Lööf L, Bodemar G, Hultcrantz R, Danielsson A, et al. Natural history and prognostic factor in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996; 38: 610–5
   PubMed Web of Science ®Google Scholar
• Angulo P, Lindor KD. Primary sclerosing cholangitis. Hepatology 1999; 30: 325–32
   PubMed Web of Science ®Google Scholar
• MacCarty RL, LaRusso NF, May GR, Bender CE, Wiesner RH, King JE, et al. Cholangiocarcinoma complicating primary sclerosing cholangitis: cholangiographic appearances. Radiology 1985; 156: 43–6
   PubMed Web of Science ®Google Scholar
• Wee A, Ludwig J, Coddey R, LaRusso NF, Wiesner RH. Hepatobiliary carcinoma associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hum Pathol 1985; 16: 719–26
   PubMed Web of Science ®Google Scholar
• Leidenius M, Höckerstedt K, Broomé U, Ericzon B-G, Friman S, Olausson M, et al. Hepatobiliary carcinoma in primary sclerosing cholangitis: a case control study. J Hepatol 2001; 34: 792–8
   PubMed Web of Science ®Google Scholar
• Boberg KM, Berquist A, Mitchell S, Pares A, Rosina F, Broomé U, et al. Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation. Scand J Gastroenterol 2002; 10: 1205–11
   Web of Science ®Google Scholar
• Broomé U, Löfberg R, Veress B, Eriksson LS. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology 1995; 22: 1404–8
   PubMed Web of Science ®Google Scholar
• Berquist A, Glaumann H, Persson B, Broomé U. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study. Hepatology 1998; 27: 311–6
   PubMed Web of Science ®Google Scholar
• Chalasani N, Baluyut A, Ismail A, Zaman A, Sood G, Ghalib R, et al. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study. Hepatology 2000; 31: 7–11
   PubMed Web of Science ®Google Scholar
• Miros M, Kerlin P, Walker N, Harper J, Lynch S, Strong R. Predicting cholangiocarcinoma in patients with primary sclerosing before transplantation. Gut 1991; 33: 1369–73
   Web of Science ®Google Scholar
• Rosen CB, Nagorney DM, Wiesner RH, Coffey RJ, LaRusso NF. Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg 1991; 213: 21–5
   PubMed Web of Science ®Google Scholar
• Nichols JC, Gores GJ, LaRusso NF, Wiesner RH, Nagorney DM, Ritts RE, Jr. Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis. Mayo Clinic Proc 1993; 68: 874–9
   PubMed Web of Science ®Google Scholar
• Ramage JK, Donaghy A, Farrant JM, Iorns R, Williams R. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology 1995; 108: 865–9
   PubMed Web of Science ®Google Scholar
• Abu-Elmagd KM, Selby R, Iwatsuki S, Fung J, Tzakis A, Todo S, et al. Cholangiocarcinoma and sclerosing cholangitis: clinical characteristics and effect on survival after liver transplantation. Transplant Proc 1993; 25: 1124–5
   PubMed Web of Science ®Google Scholar
• Knechtle SJ, S'Alessandro, Harms BA, Pirch JD, Belzer FO, Kalayoglu M. Relationships between sclerosing cholangitis, inflammatory bowel disease and cancer in patients undergoing liver transplantation. Surgery 1995;118:615–20.
   PubMed Web of Science ®Google Scholar
• Nashan B, Schlitt HJ, Tusch G, Oldhafer KJ, Ringe B, Wagner S, et al. Biliary malignancies in primary sclerosing cholangitis: timing for liver transplantation. Hepatology 1996; 23: 1105–11
   PubMed Web of Science ®Google Scholar
• Ludwig J, Barham SS, LaRusso NF, Elveback LR, Wiesner RH, McCall JT. Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology 1981; 1: 632–40
   PubMedGoogle Scholar
• Evans JG, Acheson ED. An epidemiological study of ulcerative colitis and regional enteritis in the Oxford area. Gut 1965; 6: 311–24
   PubMed Web of Science ®Google Scholar
• Farmer R, Mawic W, Turnbull R. Clinical patterns in Crohn's disease: a statistical study of 6155 cases. Gastroenterology 1975; 68: 627–35
   PubMed Web of Science ®Google Scholar
• Weinbren K, Mutum SS. Pathological aspects of cholangiocarcinoma. J Pathol 1983; 139: 217–38
   PubMed Web of Science ®Google Scholar
• Yen S, Hseih C, MacMahon B. Extrahepatic bile duct cancer and smoking, beverage consumption, past medical history, and oral contraceptive use. Cancer 1987; 59: 1112–6
   PubMed Web of Science ®Google Scholar
• Loftus EV, Jr, Sandborn WJ, Tremaine WJ, Mahoney DW, Zinsmeister AR, Offord KP, et al. Primary sclerosing cholangitis is associated with nonsmoking: a case control study. Gastroenterology 1996; 110: 1496–502
   PubMed Web of Science ®Google Scholar
• Van Erpecum KJ, Smits SJHM, Van de Meeberg PC, Linn FHH, Wolfhagen FHJ, vanBerge-Henegouwen GP, et al. Risk of primary sclerosing cholangitis is associated with nonsmoking behaviour. Gastroenterology 1996; 110: 1503–6
   PubMed Web of Science ®Google Scholar
• Jalanko H, Kuusela P, Roberts P, Sipponen P, Haglund C, Mäkelä O. Comparison of a new tumour marker, CA 19-9, with a-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases. J Clin Pathol 1984; 37: 218–22
   PubMed Web of Science ®Google Scholar
• De Vreede I, Steers J, Burch P, Rosen C, Gunderson L, Haddock M, et al. Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl 2000; 6: 309–16
   PubMed Web of Science ®Google Scholar
• Nimura Y, Kamiya J, Hayakawa N, Shionya S. Cholangioscopic differentiation of biliary stricures and polyps. Endoscopy 1989; 21: 351–6
   PubMed Web of Science ®Google Scholar
• Nimura Y. Staging of biliary carcinoma: cholangiography and cholangioscopy. Endoscopy 1993; 25: 76–80
   PubMed Web of Science ®Google Scholar
• Seo DW, Kim MH, Lee SK, Myung SJ, Jang GH, Ha HK, et al. Usefulness of cholangioscopy in patients with focal stricture of the intrahepatic duct unrelated to intrahepatic stones. Gastrointest Endosc 1999; 49: 204–9
   PubMed Web of Science ®Google Scholar
• Domagk D, Poremba C, Dietl K-H, Senninger N, Heinecke A, Domschke W, et al. Endoscopic transpapillary biopsies and intraductal ultrasonography in the diagnostics of bile duct strictures: a prospective study. Gut 2002; 51: 240–4
   PubMed Web of Science ®Google Scholar
• Vazquez-Sequeiros E, Baron TH, Clain JE, Gostout CJ, Norton ID, Petersen BT, et al. Evaluation of indeterminate bile duct strictures by intraductal US. Gastrointest Endosc 2002; 56: 372–9
   PubMed Web of Science ®Google Scholar